Cite
TCR engineered T cells for solid tumor immunotherapy.
MLA
Zhang, Yikai, et al. “TCR Engineered T Cells for Solid Tumor Immunotherapy.” Experimental Hematology & Oncology, vol. 11, no. 1, June 2022, pp. 1–11. EBSCOhost, https://doi.org/10.1186/s40164-022-00291-0.
APA
Zhang, Y., Liu, Z., Wei, W., & Li, Y. (2022). TCR engineered T cells for solid tumor immunotherapy. Experimental Hematology & Oncology, 11(1), 1–11. https://doi.org/10.1186/s40164-022-00291-0
Chicago
Zhang, Yikai, Zhipeng Liu, Wei Wei, and Yangqiu Li. 2022. “TCR Engineered T Cells for Solid Tumor Immunotherapy.” Experimental Hematology & Oncology 11 (1): 1–11. doi:10.1186/s40164-022-00291-0.